CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,939,756
- in 9 filings, $1.9M under 10b5-1 plans
Net −$1,939,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-15 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −1,292 | $45.04 | $58K | 39,562 |
| 2023-02-15 | Gutwerg Ori SVP, GENERICS | Shares withheld for taxes | −1,275 | $45.04 | $57K | 36,369 |
| 2022-12-01 | MERIDIAN VENTURE PARTNERS II LP 10% owner | Sale | −200,000 | $38.50 | $7.7M | 2,019,259 |
| 2022-09-12 | Davis Krista SVP, CHIEF HR OFFICER | Grant or award | +16,433 | 16,433 | ||
| 2022-09-08 | Lalwani Nikhil PRESIDENT & CEO | Shares withheld for taxes | −3,646 | $37.61 | $137K | 281,957 |
| 2022-08-15 | Marken James G. SVP OPS & PROD DEV | Sale | −5,172 | $37.79 | $195K | 117,642 |
| 2022-08-12 | Marken James G. SVP OPS & PROD DEV | Sale | −12,894 | $37.04 | $478K | 122,814 |
| 2022-07-18 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Grant or award | +19,280 | 19,280 | ||
| 2022-04-27 | Gutwerg Ori SVP, GENERICS | Grant or award | +6,476 | 37,644 | ||
| 2022-04-27 | Mutz Christopher HEAD OF RARE DISEASE | Grant or award | +6,476 | 40,854 | ||
| 2022-04-27 | Marken James G. SVP OPS & PROD DEV | Grant or award | +6,644 | 135,708 | ||
| 2022-04-27 | CAREY STEPHEN P. SENIOR VICE PRESIDENT AND CFO | Grant or award | +11,291 | 146,633 | ||
| 2022-04-27 | Lalwani Nikhil PRESIDENT & CEO | Grant or award | +33,352 | 285,603 | ||
| 2022-04-27 | HAUGHEY THOMAS Director | Grant or award | +10,049 | 40,251 | ||
| 2022-04-27 | NASH DAVID Director | Grant or award | +10,049 | 31,696 | ||
| 2022-04-27 | Pera Antonio R Director | Grant or award | +10,049 | 29,762 | ||
| 2022-04-27 | Thoma Jeanne Director | Grant or award | +10,049 | 29,334 | ||
| 2022-04-27 | Walsh Patrick D Director | Grant or award | +10,049 | 63,437 | ||
| 2022-04-27 | Brown Robert E. JR Director | Grant or award | +10,049 | 49,021 | ||
| 2022-04-10 | Marken James G. SVP OPS & PROD DEV | Shares withheld for taxes | −1,878 | $29.91 | $56K | 129,064 |
Page 22 of 23 · 442 trades